How Different Wavelengths of the Ultraviolet Spectrum Contribute to Skin Carcinogenesis: The Role of Cellular Damage Responses  by Rünger, Thomas M.
COMMENTARY
 www.jidonline.org 2103
J Am Acad Dermatol 49:832–41
American Cancer Society (2006) Cancer Facts and 
Figures 2006. <http://www.cancer.org/docroot/
STT/content/STT_1x_Cancer_Facts__Figures_
2006.asP>
Hodgson NC (2005) Merkel cell carcinoma: 
changing incidence trends. J Surg Oncol 89:1–
4
Houben R, Michel B, Vetter-Kauczok CS, Pfohler C, 
Laetsch B, Wolter MD et al. (2006) Absence 
of classical MAP kinase pathway signalling 
in Merkel cell carcinoma. J Invest Dermatol 
126:1135–42
Houben R, Ortmann, S, Schrama D, Herold MJ, 
Berberich I, Reichardt HM et al. (2007) 
Activation of the MAP kinase pathway induces 
apoptosis in the Merkel cell carcinoma cell line 
UISO. J Invest Dermatol 127:2116–22
Kennedy MM, Blessing K, King G, Kerr KM (1996) 
Expression of bcl-2 and p53 in Merkel cell 
carcinoma. An immunohistochemical study. 
Am J Dermatopathol 18:273–7
Liu S, Daa T, Kashima K, Kondoh Y, Yokoyama S 
(2007) The Wnt-signaling pathway is not 
implicated in tumorigenesis of Merkel cell 
carcinoma. J Cutan Pathol 34:22–6
Plettenberg A, Pammer J, Tschachler E (1996) 
Merkel cells and Merkel cell carcinoma express 
the BCL-2 proto-oncogene. Exp Dermatol 
5:183–8
Popp S, Waltering S, Herbst C, Moll I, Boukamp P 
(2002) UV-B-type mutations and chromosomal 
imbalances indicate common pathways for the 
development of Merkel and skin squamous cell 
carcinomas. Int J Cancer 99:352–60
Schlagbauer-Wadl H, Klosner G, Heere-Ress E, 
Waltering S, Moll I, Wolff K, et al. (2000) Bcl-
2 antisense oligonucleotides (G3139) inhibit 
Merkel cell carcinoma growth in SCID mice. 
J Invest Dermatol 114:725–30
Schubbert S, Shannon K, Bollag G (2007) 
Hyperactive Ras in developmental disorders 
and cancer. Nat Rev Cancer 7:295–308
Swick BL, Ravdel L, Fitzpatrick JE, Robinson WA 
(2007) Merkel cell carcinoma: evaluation 
of KIT (CD117) expression and failure to 
demonstrate activating mutations in the C-KIT 
proto-oncogene—implications for treatment 
with imatinib mesylate. J Cutan Pathol 34:324–
9
Van Gele M, Kaghad M, Leonard JH, Van Roy N, 
Naeyaert JM, Geerts ML et al. (2000) Mutation 
analysis of P73 and TP53 in Merkel cell 
carcinoma. Br J Cancer 82:823–6
Van Gele M, Leonard JH, Van Roy N, Cook AL, 
De Paepe A, Speleman F (2001) Frequent 
allelic loss at 10q23 but low incidence of 
PTEN mutations in Merkel cell carcinoma. Int 
J Cancer 92:409–13
Van Gompel JJ, Kunnimalaiyaan M, Holen K, 
Chen H (2005) ZM336372, a Raf-1 activator, 
suppresses growth and neuroendocrine 
hormone levels in carcinoid tumor cells. Mol 
Cancer Ther 4:910–7
Weinstock MA, Gardstein B (1999) Twenty-
year trends in the reported incidence of 
mycosis fungoides and associated mortality. 
Am J Public Health 89:1240–4
See related article on pg 2236
How Different Wavelengths of the 
Ultraviolet Spectrum Contribute to 
Skin Carcinogenesis: The Role of 
Cellular Damage Responses
Thomas M. Rünger1
The carcinogenic properties of ultraviolet (UV) light are mediated by its ability 
to generate DNA damage. Cellular responses to UV-induced DNA damage pro-
foundly modulate the carcinogenic effects of UV exposures, and these responses 
are wavelength dependent. However, the exact contributions of different wave-
lengths of UV light to DNA damage, cellular damage responses, mutation, and 
skin carcinogenesis are incompletely understood. Given that UV-induced apop-
tosis is a protective cellular response to UV that prevents survival of damaged 
cells, inhibition of UVB-induced apoptosis by adding UVA, as reported by Ibuki 
et al. in this issue, may be a mechanism by which UVA augments UVB-mediated 
mutation and skin cancer formation.
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Photocarcinogenesis is most common-
ly thought to be the result of a chain of 
events that involve formation of DNA 
damage and subsequent mutation for-
mation following exposure to ultra-
violet light (UV) (Figure 1) (Rünger, 
2003). Several cellular defense mech-
anisms reduce the likelihood that one 
occurrence in this cascade leads to the 
next (Figure 1). Many of these protec-
tive responses can be induced by UV, 
thereby providing additional protec-
tion against subsequent exposures. All 
of these responses are mediated by a 
tightly controlled network of signaling 
pathways, many of which involve the 
tumor suppressor p53. UV-induced 
mutations of p53 with subsequent dis-
ruption of cellular damage responses 
are a hallmark of most sun-induced 
cutaneous squamous-cell carcino-
mas (Brash et al., 1996). This further 
underlines the importance of these 
damage responses for the prevention 
of photocarcinogenesis.
The melanin microparasol that cov-
ers the nucleus of basal keratinocytes 
reduces formation of DNA damage 
with exposure of the skin to UV. Once 
DNA damage is formed, most of it 
is repaired and does not give rise to 
mutations. This is exemplified by the 
genodermatosis xeroderma pigmen-
tosum, in which the relative inability 
to repair UV-induced DNA damage 
results in UV hypermutability in cells 
and an increased frequency of skin 
cancers in UV-exposed areas of affect-
ed patients. Another mechanism that 
inhibits mutation formation at sites 
of DNA damage is a G1/S cell–cycle 
arrest that prevents cells from rep-
licating damaged DNA, a situation 
particularly prone to the introduction 
of mutations (Decraene et al., 2001). 
DNA polymerase η, which is mutated 
in xeroderma pigmentosum variant, 
is a translesion DNA polymerase spe-
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cialized to bypass DNA photoprod-
ucts. It is downregulated through 
(UV-induced) activation of p53, which 
maintains a low mutagenic activity at 
the price of a reduced damage bypass 
(Avkin et al., 2006). Activation of dam-
age response signaling pathways often 
results in apoptosis of UV-irradiated 
cells. This prevents survival of cells 
with overwhelming DNA damage 
and thereby prevents the rise of cells 
with UV-induced mutations. Even 
after mutations have been established, 
most of these cells will be removed 
by immune-mediated cell killing. This 
immune surveillance plays an impor-
tant role in the prevention of cancer 
formation. However, it is inhibited in 
the skin by sun exposure.
The relative contributions of differ-
ent wavelengths of the solar UV spec-
trum—in particular UVA (315–400 
nm) and UVB (280–315 nm)—to these 
UV-induced cellular events (DNA 
damage, damage responses, muta-
tion formation, and carcinogenesis) 
are only incompletely understood. We 
recently published a spectrum of UVA- 
and UVB-induced mutations for the 
first time in non-immortalized, normal 
human skin cells (Kappes et al., 2006). 
Because UVA is only a weak generator 
of DNA photoproducts (cyclobutane 
pyrimidine dimers and 6,4-photoprod-
ucts), we were surprised to find that 
UVA induced a very similar spectrum 
of mutations as compared with UVB, 
demonstrating that DNA photoprod-
ucts are the main type of premutagenic 
DNA damage, not only with UVB but 
also with UVA. Attempting to explain 
a higher mutation rate per photoprod-
uct with UVA, which according to our 
results is not explainable by a different 
type of DNA damage, we hypothesized 
that UVA induces more mutations 
at sites of DNA damage than UVB, 
because it induces only a weaker pro-
tective DNA damage response (Kappes 
et al., 2006; Rünger and Kappes, in 
the press). Indeed, we found a much 
weaker and shorter-lived activation of 
p53 by UVA as compared with UVB.
Ibuki et al. (2007, this issue) pro-
vide compelling evidence that add-
ing increasing doses of UVA (67, 
110, and 168 kJ/m2) to a constant 
very high dose of UVB (3780 J/m2) 
decreases epidermal apoptosis in an 
in vivo mouse model, as shown by a 
decreased number of sunburn cells 
and caspase-3-positive cells and less 
apoptotic DNA fragmentation. The 
relevance of these data for photocar-
cinogenesis can be interpreted in two 
ways. First, as favored by Ibuki et al., 
a decrease in the number of sunburn 
cells could reflect reduced formation 
of DNA damage. However, a reduc-
tion in DNA damage formation by 
adding UVA to UVB was not shown, 
and it is difficult to imagine how add-
ing a DNA damaging agent to another 
one could result in less damage.
The second way to project effects of 
the phenomenon described by Ibuki et 
al. on photocarcinogenesis is to under-
stand, as outlined above, apoptosis as 
a protective, antimutagenic, and anti-
carcinogenic cellular response. With 
this understanding, inhibition of apop-
tosis would be expected to increase 
mutation burden and, ultimately, skin 
cancer rates. It will be interesting to 
see which of the two projections will 
be confirmed, because Ibuki et al. are 
apparently undertaking such experi-
ments at this time.
The influence of UVA on UVB/
UVA skin carcinogenesis in mice has 
already been studied, albeit not with 
exactly the same experimental setup 
as that used by Ibuki et al. UVA irra-
diation augmented the carcinogenic 
effects of mixed UVB/UVA in two 
studies (Staberg et al., 1983; Willis et 
al., 1981) and diminished or had no 
effect in two other studies (Forbes et 
al., 1978; Bech-Thomsen et al., 1994). 
In one of the latter two studies (Bech-
Thomsen et al., 1994), a diminished 
rate of UVB-induced tumors was 
observed with low doses, but not with 
a higher dose of UVA.
To expand our hypothesis (see 
above), UVA not only appears to 
induce a weaker DNA damage 
response than UVB but may even 
inhibit it. For practical applications, 
this would mean that UVA protection 
is indeed very important for the pre-
vention of photocarcinogenesis. The 
speculation by Ibuki et al. that UVA 
may be used for protection against the 
photocarcinogenic properties of UVB 
may be interesting, because it is pro-
vocative and questions current think-
ing. However, much more evidence 
is required to change current recom-
mendations for UVA photoprotection.
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Figure 1. The photocarcinogenesis chain of events and intrinsic protective mechanisms for the 
prevention of skin cancer formation following sun exposure. *Although UVB readily induces apoptosis, 
adding UVA inhibits UVB-induced apoptosis, as reported in this issue by Ibuki et al. (2007).
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